摘要
肝肾综合征(HRS)是肝硬化、肝衰竭患者病程晚期时发生的一种潜在的可逆的肾衰竭,其主要发病机制是有效循环血量不足,心功能不全和肾脏低灌注。HRS的发病与多种生物活性物质关系密切,现将肝肾综合征发病机制研究现状做一综述。
Hepatorenal syndrome(HRS)was a potentially reversible renal failure in patients with advanced cirrhosis and liver failure.Its main pathogenesis was insufficient effective circulating blood,cardiac insufficiency and renal hypoperfusion.The pathogenesis of HRS was closely related to a variety of bioactive substances.This article reviews the current research status of the pathogenesis of hepatorenal syndrome.
作者
邹波
朱啸峰
张鑫垚
ZOU Bo;ZHU Xiao-feng;ZHAGN Xin-tuo(Department of Liver of Ninth Hospital of Nanchang,330002 China;Department of Liver Disease of Second People's Hospital of Shangrao 334000 China)
出处
《现代诊断与治疗》
CAS
2019年第11期1816-1819,共4页
Modern Diagnosis and Treatment
关键词
肝肾综合征
发病机制
研究
现状
Hepatorenal Syndrome
Pathogenesis
Research
Current Situation
